Business Description
Orphazyme AS
ISIN : DK0062502894
Share Class Description:
OCSE:ORPHA: Ordinary SharesCompare
Compare
Traded in other countries / regions
ORPHA.Denmark1TB0.Germany0CUM.UKOZYMF.USA IPO Date
2017-11-21Description
Orphazyme AS has defined a new technique and has currently entered into a strategic partnership with the Swedish-listed company CombiGene AB. The company objects to engage in activities and investments related to biopharmaceutical research and development.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 39.4 | |||||
| 9-Day RSI | 41.02 | |||||
| 14-Day RSI | 42.31 | |||||
| 6-1 Month Momentum % | 47.62 | |||||
| 12-1 Month Momentum % | -64.75 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| FCF Margin % | -1994.37 |
GF Value Rank
| Name | Current | Vs Industry | Vs History |
|---|
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Orphazyme AS Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil kr) | 36.193 | ||
| EPS (TTM) (kr) | -2880 | ||
| Beta | 0.43 | ||
| Volatility % | 103.98 | ||
| 14-Day RSI | 42.31 | ||
| 14-Day ATR (kr) | 68.816517 | ||
| 20-Day SMA (kr) | 1039.535 | ||
| 12-1 Month Momentum % | -64.75 | ||
| 52-Week Range (kr) | 407 - 3855 | ||
| Shares Outstanding (Mil) | 0.04 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Orphazyme AS Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Orphazyme AS Stock Events
| Event | Date | Price(kr) | ||
|---|---|---|---|---|
| No Event Data | ||||
Orphazyme AS Frequently Asked Questions
What is Orphazyme AS(OCSE:ORPHA)'s stock price today?
The current price of OCSE:ORPHA is kr1009.80. The 52 week high of OCSE:ORPHA is kr3855.00 and 52 week low is kr407.00.
When is next earnings date of Orphazyme AS(OCSE:ORPHA)?
The next earnings date of Orphazyme AS(OCSE:ORPHA) is 2024-08-20.
Does Orphazyme AS(OCSE:ORPHA) pay dividends? If so, how much?
Orphazyme AS(OCSE:ORPHA) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers